Growth Metrics

BioNTech SE (BNTX) Other Non-Current Liabilities (2018 - 2025)

BioNTech SE's Other Non-Current Liabilities history spans 8 years, with the latest figure at $169.1 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 9.31% to $169.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $169.1 million, a 9.31% increase, with the full-year FY2025 number at $164.2 million, up 6.09% from a year prior.
  • Other Non-Current Liabilities hit $169.1 million in Q4 2025 for BioNTech SE, down from $247.3 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for BNTX hit a ceiling of $803.3 million in Q3 2024 and a floor of $6.8 million in Q1 2021.
  • Historically, Other Non-Current Liabilities has averaged $338.9 million across 5 years, with a median of $316.8 million in 2023.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 25243.82% in 2021 and later plummeted 69.22% in 2025.
  • Tracing BNTX's Other Non-Current Liabilities over 5 years: stood at $211.5 million in 2021, then skyrocketed by 77.12% to $374.6 million in 2022, then dropped by 22.66% to $289.8 million in 2023, then crashed by 46.6% to $154.7 million in 2024, then rose by 9.31% to $169.1 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for BNTX at $169.1 million in Q4 2025, $247.3 million in Q3 2025, and $164.8 million in Q2 2025.